Laurus Investment Counsel Inc. Emergent Bio Solutions Inc. Transaction History

Laurus Investment Counsel Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$56.61 - $80.46 $4.26 Million - $6.05 Million	-75,234 Closed	0 $0
Q1 2021 Jul 20, 2021	SELL	$86.23 - $125.19 $3.9 Million - $5.67 Million	-45,270 Reduced 37.57%	75,234 $6.99 Million
Q4 2020 Jul 20, 2021	BUY	$79.17 - $111.47 $40,376 - $56,849	510 Added 0.43%	120,504 $10.8 Million
Q3 2020 Jul 20, 2021	SELL	$81.91 - $134.94 $3.47 Million - $5.72 Million	-42,375 Reduced 26.1%	119,994 $12.4 Million
Q2 2020 Jul 20, 2021	BUY	$54.33 - $89.52 $4.79 Million - $7.9 Million	88,200 Added 118.92%	162,369 $12.8 Million

Q1 2020 Jul 20, 2021	BUY	$49.34 - $68.76 $2.36 Million - $3.29 Million	47,790 Added 181.17%	74,169 $4.29 Million
Q3 2019 Jul 20, 2021	BUY	$40.6 - $57.2 $1.07 Million - $1.51 Million	26,379 New	26,379 $1.38 Million

192

41.3M

899K

256K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Laurus Investment Counsel Inc., based on Form 13F filings with the SEC.

Stay updated on Laurus Investment Counsel Inc. with notifications on news.